Cubist Systematic Strategies’s PDS Biotechnology PDSB Stock Holding History

Cubist Systematic Strategies’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,861	Closed	-$14.4K	–	3412
2025 Q2	$14.4K	Buy	+10,861	New	+$14.7K	﹤0.01%	2834
2024 Q4	–	Sell	-18,195	Closed	-$69.5K	–	3417
2024 Q3	$69.5K	Sell	18,195 -31,580	-63%	-$105K	﹤0.01%	2734
2024 Q2	$146K	Buy	+49,775	New	+$159K	﹤0.01%	2569
2023 Q2	–	Sell	-163,507	Closed	-$1.01M	–	4107
2023 Q1	$1.01M	Buy	163,507 +107,197	+190%	+$877K	0.01%	2183
2022 Q4	$743K	Buy	56,310 +30,008	+114%	+$212K	﹤0.01%	2707
2022 Q3	$78K	Buy	+26,302	New	+$112K	﹤0.01%	4066
2022 Q1	–	Sell	-64,663	Closed	-$524K	–	3723
2021 Q4	$524K	Sell	64,663 -6,955	-10%	-$74.8K	0.01%	2419
2021 Q3	$1.07M	Buy	71,618 +46,665	+187%	+$582K	0.01%	1467
2021 Q2	$313K	Buy	+24,953	New	+$195K	﹤0.01%	2303

Other funds holding PDSB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's PDSB Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of PDS Biotechnology (PDSB) in Q3 2025, closing a stake of 10,861 shares — an estimated $14.4K sold.

Cubist Systematic Strategies first reported a position in PDSB in Q2 2021 and held it in 9 quarters. The position peaked at $1.07M in Q3 2021. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2025.

Cubist Systematic Strategies reported no remaining PDS Biotechnology position as of Q3 2025 after selling out during the quarter.
Cubist Systematic Strategies sold 10,861 PDS Biotechnology shares in Q3 2025, an estimated $14.4K.
Cubist Systematic Strategies first reported a position in PDS Biotechnology in Q2 2021 and held it in 9 quarters.
Cubist Systematic Strategies's PDS Biotechnology position peaked at $1.07M in Q3 2021.
47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.